Aehr Test Systems (AEHR)vsLam Research Corp (LRCX)
AEHR
Aehr Test Systems
$94.69
+0.94%
TECHNOLOGY · Cap: $3.06B
LRCX
Lam Research Corp
$298.22
+0.07%
TECHNOLOGY · Cap: $373.17B
Smart Verdict
WallStSmart Research — data-driven comparison
Lam Research Corp generates 46364% more annual revenue ($23.23B vs $50.00M). LRCX leads profitability with a 31.3% profit margin vs -14.2%. AEHR appears more attractively valued with a PEG of 0.90. LRCX earns a higher WallStSmart Score of 78/100 (B+).
AEHR
Hold38
out of 100
Grade: F
LRCX
Strong Buy78
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AEHR.
Margin of Safety
+15.2%
Fair Value
$351.66
Current Price
$298.22
$53.44 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 33.7% year-over-year
Conservative balance sheet, low leverage
Growing faster than its price suggests
Mega-cap, among the largest globally
Every $100 of equity generates 58 in profit
Keeps 31 of every $100 in revenue as profit
Strong operational efficiency at 37.4%
Revenue surging 30.0% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
Trading at 14.0x book value
Weak financial health signals
ROE of -8.2% — below average capital efficiency
Earnings declined 87.5%
Premium valuation, high expectations priced in
Trading at 29.9x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : AEHR
The strongest argument for AEHR centers on Revenue Growth, Debt/Equity, PEG Ratio. Revenue growth of 33.7% demonstrates continued momentum. PEG of 0.90 suggests the stock is reasonably priced for its growth.
Bull Case : LRCX
The strongest argument for LRCX centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 31.3% and operating margin at 37.4%. Revenue growth of 30.0% demonstrates continued momentum.
Bear Case : AEHR
The primary concerns for AEHR are Price/Book, Piotroski F-Score, Return on Equity.
Bear Case : LRCX
The primary concerns for LRCX are P/E Ratio, Price/Book. A P/E of 51.9x leaves little room for execution misses.
Key Dynamics to Monitor
AEHR profiles as a hypergrowth stock while LRCX is a growth play — different risk/reward profiles.
AEHR carries more volatility with a beta of 3.07 — expect wider price swings.
AEHR is growing revenue faster at 33.7% — sustainability is the question.
LRCX generates stronger free cash flow (822M), providing more financial flexibility.
Bottom Line
LRCX scores higher overall (78/100 vs 38/100), backed by strong 31.3% margins and 30.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aehr Test Systems
TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA
Aehr Test Systems primarily designs, designs, manufactures and sells test and burn equipment for use in the semiconductor industry in the United States, Asia and Europe. The company is headquartered in Fremont, California.
Visit Website →Lam Research Corp
TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA
Lam Research Corporation is an American corporation that engages in the design, manufacture, marketing, and service of semiconductor processing equipment used in the fabrication of integrated circuits. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices (transistors, capacitors) and their wiring (interconnects). The company also builds equipment for back-end wafer-level packaging (WLP), and for related manufacturing markets such as for microelectromechanical systems (MEMS). The company is headquartered in Fremont, California, in the Silicon Valley.
Compare with Other SEMICONDUCTOR EQUIPMENT & MATERIALS Stocks
Want to dig deeper into these stocks?